Bulls N’ Bears ASX Runner of the Week is… Kalgoorlie Gold Mining. The company’s share price rocketed after it made a WA gold ...

Shares of Equillium (NASDAQ:EQ) soared 26% Thursday after the company and partner Biocon reported positive topline results from a Phase 2 study of the drug itolizumab in the treatment of moderate to ...

Itolizumab demonstrated clinical efficacy after 12 weeks of treatment, achieving a clinical remission rate of 23.3% compared to 20.0% for adalimumab and 10.0% ...

Though the baseline illness severity was uneven, with more severe patients in the itolizumab arm, the medication showed great ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...

Scores of projects both big and small in Washington County will be receiving a portion of more than $10 million in Local Share Account gambling revenue this year after the commissioners voted ...

Lloyd Baggs has come full circle back to guitar design as a bespoke platform for his latest pickup system – the result could ...